Free Trial

CVRx (CVRX) Competitors

CVRx logo
$7.24 -0.09 (-1.16%)
As of 01:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CVRX vs. AXGN, EMBC, IRMD, SIBN, BVS, RXST, BFLY, AVNS, CBLL, and KIDS

Should you be buying CVRx stock or one of its competitors? The main competitors of CVRx include AxoGen (AXGN), Embecta (EMBC), Iradimed (IRMD), SI-BONE (SIBN), Bioventus (BVS), RxSight (RXST), Butterfly Network (BFLY), Avanos Medical (AVNS), CeriBell (CBLL), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

CVRx vs.

AxoGen (NASDAQ:AXGN) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, community ranking, valuation and earnings.

AxoGen currently has a consensus price target of $22.60, suggesting a potential upside of 34.16%. CVRx has a consensus price target of $17.60, suggesting a potential upside of 143.26%. Given CVRx's higher probable upside, analysts plainly believe CVRx is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AxoGen
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
CVRx
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

AxoGen has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, CVRx has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500.

AxoGen has higher revenue and earnings than CVRx. AxoGen is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AxoGen$187.34M3.99-$21.72M-$0.22-76.57
CVRx$51.29M3.68-$59.97M-$2.69-2.69

AxoGen received 422 more outperform votes than CVRx when rated by MarketBeat users. However, 74.47% of users gave CVRx an outperform vote while only 72.89% of users gave AxoGen an outperform vote.

CompanyUnderperformOutperform
AxoGenOutperform Votes
457
72.89%
Underperform Votes
170
27.11%
CVRxOutperform Votes
35
74.47%
Underperform Votes
12
25.53%

AxoGen has a net margin of -7.91% compared to CVRx's net margin of -116.91%. AxoGen's return on equity of -14.91% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
AxoGen-7.91% -14.91% -7.49%
CVRx -116.91%-93.06%-51.78%

In the previous week, AxoGen had 2 more articles in the media than CVRx. MarketBeat recorded 7 mentions for AxoGen and 5 mentions for CVRx. AxoGen's average media sentiment score of 1.33 beat CVRx's score of 1.11 indicating that AxoGen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AxoGen
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CVRx
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

80.3% of AxoGen shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 7.0% of AxoGen shares are held by company insiders. Comparatively, 18.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

AxoGen beats CVRx on 11 of the 17 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVRX vs. The Competition

MetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$189.12M$4.33B$5.49B$7.94B
Dividend YieldN/A39.94%5.11%4.23%
P/E Ratio-2.7030.4822.5818.55
Price / Sales3.6855.07397.25103.00
Price / CashN/A51.0838.1834.62
Price / Book2.656.046.704.26
Net Income-$59.97M$68.71M$3.23B$248.39M
7 Day Performance11.65%-0.48%1.26%1.27%
1 Month Performance-42.26%-2.60%3.75%3.85%
1 Year Performance-28.51%22.52%15.78%5.23%

CVRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVRX
CVRx
3.1125 of 5 stars
$7.24
-1.2%
$17.60
+143.3%
-52.8%$189.12M$51.29M-2.70160Upcoming Earnings
Short Interest ↓
News Coverage
Positive News
AXGN
AxoGen
2.8984 of 5 stars
$16.18
-1.3%
$22.60
+39.7%
+153.8%$717.49M$187.34M-50.56450Positive News
EMBC
Embecta
4.5882 of 5 stars
$12.32
+3.7%
$20.33
+65.0%
+20.3%$716.21M$1.11B12.321,900Positive News
IRMD
Iradimed
4.8043 of 5 stars
$53.02
-0.6%
$72.00
+35.8%
+29.1%$674.15M$73.24M35.35110Positive News
SIBN
SI-BONE
4.1734 of 5 stars
$14.47
+0.4%
$24.40
+68.6%
-4.3%$614.30M$167.18M-15.73350Upcoming Earnings
News Coverage
Positive News
BVS
Bioventus
3.279 of 5 stars
$7.43
-2.9%
$15.00
+101.9%
+84.6%$608.84M$573.28M-12.181,200Positive News
RXST
RxSight
2.6454 of 5 stars
$14.56
-2.6%
$37.60
+158.2%
-71.8%$591.43M$139.93M-17.54220Upcoming Earnings
BFLY
Butterfly Network
2.5531 of 5 stars
$2.43
-0.4%
$3.00
+23.5%
+198.6%$590.30M$82.06M-5.28460Upcoming Earnings
Insider Trade
News Coverage
Gap Up
AVNS
Avanos Medical
2.164 of 5 stars
$12.68
+2.7%
N/A-30.6%$583.32M$687.80M37.294,040Upcoming Earnings
Short Interest ↑
Analyst Revision
High Trading Volume
CBLL
CeriBell
2.2024 of 5 stars
$16.19
+5.7%
$32.50
+100.7%
N/A$580.70M$65.44M0.00N/ANews Coverage
Positive News
KIDS
OrthoPediatrics
4.1396 of 5 stars
$21.77
+1.1%
$37.00
+70.0%
-29.7%$528.73M$204.73M-17.70200Upcoming Earnings
Positive News

Related Companies and Tools


This page (NASDAQ:CVRX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners